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Caveolin-3 (Cav-3) is a protein that has been implicated in t-tubule
formation and function in cardiac ventricular myocytes. In cardiac
hypertrophy and failure, Cav-3 expression decreases, t-tubule struc-
ture is disrupted, and excitation-contraction coupling is impaired.
However, the extent to which the decrease in Cav-3 expression
underlies these changes is unclear. We therefore investigated the
structure and function of myocytes isolated from the hearts of Cav-3
knockout (KO) mice. These mice showed cardiac dilatation and
decreased ejection fraction in vivo compared with wild-type control
mice. Isolated KO myocytes showed cellular hypertrophy, altered
t-tubule structure, and decreased L-type Ca2 channel current (ICa)
density. This decrease in density occurred predominantly in the
t-tubules, with no change in total ICa, and was therefore a consequence
of the increase in membrane area. Cav-3 KO had no effect on L-type
Ca2 channel expression, and C3SD peptide, which mimics the
scaffolding domain of Cav-3, had no effect on ICa in KO myocytes.
However, inhibition of PKA using H-89 decreased ICa at the surface
and t-tubule membranes in both KO and wild-type myocytes. Cav-3
KO had no significant effect on Na/Ca2 exchanger current or Ca2
release. These data suggest that Cav-3 KO causes cellular hypertro-
phy, thereby decreasing t-tubular ICa density.
NEW & NOTEWORTHY Caveolin-3 (Cav-3) is a protein that
inhibits hypertrophic pathways, has been implicated in the formation
and function of cardiac t-tubules, and shows decreased expression in
heart failure. This study demonstrates that Cav-3 knockout mice show
cardiac dysfunction in vivo, while isolated ventricular myocytes show
cellular hypertrophy, changes in t-tubule structure, and decreased
t-tubular L-type Ca2 current density, suggesting that decreased
Cav-3 expression contributes to these changes in cardiac hypertrophy
and failure.
calcium current; calcium release; calcium transient; caveolin-3
INTRODUCTION
Excitation-contraction coupling (ECC) in cardiac myocytes
is initiated by the action potential, which activates sarcolemmal
L-type Ca2 channels (LTCCs), causing Ca2 influx [Ca2
current (ICa)]. ICa triggers Ca2 release from adjacent sarco-
plasmic reticulum (SR) via Ca2 release channels [ryanodine
receptors (RyRs)]. This Ca2-induced Ca2 release (CICR)
(20) produces local increases of cytosolic Ca2 concentration
[Ca2 sparks (17)] that summate to form the cytosolic Ca2
transient, leading to contraction. In ventricular myocytes, ICa,
and thus RyR activation, occurs predominantly at specialized
invaginations of the sarcolemma called t-tubules (15, 34, 40).
This arrangement achieves near-synchronous Ca2 release
(16), and thus contraction, throughout the cell. Relaxation
occurs as cytosolic Ca2 concentration decreases, mainly be-
cause of reuptake into the SR but also by removal from the cell
via the Na/ Ca2 exchanger (NCX) (37).
Caveolin-3 (Cav-3) is a cholesterol-binding protein that is
critical to the formation of caveolae and has been implicated
in t-tubule formation (39) and localizing LTCC regulatory
proteins and ICa to the t-tubules (2). C3SD peptide, which
mimics the scaffolding domain of Cav-3 (19, 22), decreases
ICa density at the t-tubules (36), which impairs local SR
Ca2 release (7, 11).
Recent work has revealed that cardiac hypertrophy and
failure are accompanied by decreased Cav-3 expression and
loss of Cav-3-dependent stimulation of ICa (11, 21, 23), and
myocytes from failing hearts commonly display impaired
SR Ca2 release (8) as a result of altered regulation of
LTCCs (11), decreased t-tubular ICa density (8, 9, 11),
disruption of t-tubule organization (29, 45, 47), and reduced
SR Ca2 content (3, 24, 35).
These data suggest that decreased Cav-3 expression may
underlie some of the phenotypic changes observed in heart
failure (HF). Indeed, global genetic knockout (KO) of Cav-3
results in a progressive cardiomyopathy characterized by ven-
tricular hypertrophy and dilation as well as reduced fractional
shortening (48). Additionally, the loss-of-function mutation in
Cav-3, T63S, has been associated with inherited hypertrophic
cardiomyopathy (28). However, the extent to which decreased
Cav-3 expression underlies the changes in ECC observed in HF
is unknown. Therefore, we investigated the effect of Cav-3 KO
on ECC in ventricular myocytes.
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METHODS
Animals. Adult (12 wk) male wild-type (WT) C57Bl/6 and ho-
mozygous Cav-3 KO mice, produced as previously described (27),
were used. All animal procedures were approved by the University of
Bristol local ethics committee and conducted in accordance with
United Kingdom legislation [Animals (Scientific Procedures) Act
1986 Amendment Regulations 2012 incorporating European Directive
2010/63/EU].
Echocardiography. In vivo cardiac structure and function were
monitored using echocardiography. Animals were anesthetized (1–3%
isoflurane), heart rate was monitored, and measurements of contractile
performance were made from M-mode images acquired from the
parasternal short axis view using a Vevo 3100 (FUJIFILM Visual-
Sonics, Toronto, ON, Canada) and MX550D transducer.
Myocyte isolation and detubulation. Ventricular myocytes were
isolated using standard enzymatic digestion via Langendorff perfusion
as previously described (7) and used on the day of isolation. Detubu-
lation (DT), the physical and functional uncoupling of t-tubules from
the surface membrane, was achieved using formamide-induced os-
motic shock, as previously described (5, 6, 32).
Western blot analysis. Protein samples [30 g of heart homogenate
for LTCCs, Cav-3, and junctophilin-2 (JPH-2); 25 g of myocyte
lysate for bridging integrator-1 (BIN-1)] were run on 4–15% gradient
SDS-PAGE gels and transferred onto Immobilon-P membranes. Blots
were probed with antibodies against Cav-3 (no. 610420, BD Trans-
duction Laboratories, San Jose, CA, dilution 1:5,000), JPH-2 (no.
40-5300, ThermoFisher Scientific, Waltham, MA, dilution 1:500),
BIN-1 (sc-23918, Santa Cruz Biotechnology, Dallas, TX, dilution
1:200), LTCCs (Alomone Laboratories, Jerusalem, Israel, dilution
1:1,000), and GAPDH (G9545, Sigma-Aldrich, St. Louis, MO, dilu-
tion 1:100,000). Protein bands were visualized and images were
captured using horseradish peroxidase-conjugated secondary antibod-
ies (W4011, -rabbit horseradish peroxidase, Promega, Madison, WI,
dilution 1:10,000; and W4021, -mouse horseradish peroxidase, Pro-
mega, dilution 1:10,000), chemiluminescence, and a G:BOX Chemi
XT4 imaging system (Syngene, Cambridge, UK). The density of the
bands was measured using ImageJ (v1.50, National Institutes of
Health, Bethesda, MD) and normalized to GAPDH.
Imaging and analysis of t-tubule structure. Cell width and length
were measured from bright-field images of isolated myocytes ob-
tained using a 0.5 numerical aperture, 16 oil-immersion objective;
the large field of view enabled many cells to be captured in a single
image. Cell volume was calculated from these measurements as
previously described (4).
Surface and t-tubular cell membranes were labeled by incubating
cells with 5 mol/l di-8-ANEPPS (ThermoFisher) for 10 min. Image
volumes were obtained using a LSM 880 confocal microscope (Zeiss,
Carl Zeiss, Oberkochen, Germany) in Airyscan “superresolution”
mode with a 1.2 numerical aperture, 40 water-immersion objective,
sampled at 40 nm in plane and 180 nm along the optical axis. The
regularity of t-tubule staining was quantified by applying a two-
dimensional (2-D) fast Fourier transform to an offset-subtracted
square region of the interior of the cell, and the power of the first
harmonic was normalized to that of the average image intensity
(P1/P0). t-Tubule density and orientation were obtained by first pro-
cessing the volumetric data with a tubule-enhancing three-dimen-
sional (3-D) filter, segmenting using an Otsu threshold in MATLAB
R2015a (Mathworks, Natick, MA), and converting to a skeleton using
ImageJ. The skeleton was used to calculate t-tubule density [length
per unit volume (in m/m3)] and local Eigenvectors for t-tubule
angles. Tubule orientation is expressed relative to the z-disk plane, so
that 0° corresponds to a transverse tubule and 90° corresponds to a
tubule that is orthogonal to the z-disk, extending along the sarcomere
(i.e., an “axial” tubule). Branch points were calculated using Skele-
tonize (2-D/3-D) in ImageJ.
DT efficiency was quantified by comparing t-tubule density in
intact and DT cells labeled with di-8-ANEPPS, as previously de-
scribed (8). In brief, one image from a volume stack was skeletonized,
and t-tubule density was calculated as the length of tubule per cell area
(in m/m2). DT efficiency (in %) was then defined as 1 – (DT cell
t-tubule density/intact cell t-tubule density)  100. DT efficiency was
similar to that observed in previous studies and was not significantly
different between cell types (WT: 90.1 1.6%, n cells/N hearts:
intact 20/4 and DT 15/2; and KO: 87.9 2.3%; n/N: intact
20/4 and DT 24/3).
ICa recording. Myocytes were placed in a chamber mounted on a
Nikon Diaphot inverted microscope. Membrane currents and cell
capacitance were recorded using the whole cell patch-clamp technique
using an Axopatch 200B, Digidata 1322A analog-to-digital converter,
and pClamp 10 (Molecular Devices, San Jose, CA). Pipette resistance
was typically 1.5–3 M when filled with pipette solution (see below),
and pipette capacitance and series resistance were compensated by
~70%. Currents were activated from a holding potential of 	80 mV
by step depolarization to 	40 mV for 200 ms (to inactivate Na
current) followed by steps to potentials between	50 and80 mV for
500 ms before repolarization to the holding potential, at a frequency
of 0.2 Hz. Absolute ICa amplitude (in pA) in intact myocytes was
measured as the difference between peak inward current and current
at the end of the depolarizing pulse; absolute ICa in the t-tubular and
surface membranes was calculated from measurements of ICa and
membrane capacitance in intact and DT myocytes with correction for
incomplete DT (DT efficiency) as previously described (8). ICa was
normalized to cell capacitance (in pF; an index of membrane area) to
calculate ICa density (in pA/pF). ICa density in the t-tubule membrane
was calculated from the loss of membrane current and capacitance
after DT; ICa density in the surface membrane was calculated from
currents measured in DT myocytes with correction for incomplete DT
as previously described (8).
NCX current recording. To record NCX current (INCX), BAPTA
was omitted from the pipette solution (see below) and replaced with
fluo-4 pentapotassium salt (ThermoFisher) to allow simultaneous
measurement of intracellular Ca2 and membrane current. Recordings
were made 5 min after breaking into the cell to allow time for dialysis.
Pipette resistance was typically 1.2–2 M when filled with pipette
solution. After a series of conditioning pulses (a 500-ms ramp from
	80 to 	40 mV followed by a step to 0 mV for 100 ms) at 1 Hz to
steady state, stimulation was stopped and intracellular Ca2 and INCX
were recorded during application of 10 mM caffeine as previously
described (26).
Latency and heterogeneity of SR Ca2 release. Intracellular Ca2
and membrane potential were recorded simultaneously along single
t-tubules in myocytes loaded with the Ca2 indicator fluo-4/AM (5
mol/l for 25 min, ThermoFisher) and the voltage-sensitive dye
di-4-AN(F)EPPTEA [0.5–1 g/ml for 15 min, kindly supplied by Dr.
Leslie Loew (49)] as previously described (8). Cells were imaged
using a Zeiss LSM 880 (see above) with the confocal pinhole set to 1
Airy unit. Line scans along a selected t-tubule were recorded at 0.51
ms/line, with excitation at 514 nm and emitted fluorescence collected
between 518 and 560 nm for Ca2 and 590–700 nm for voltage. Ca2
release at the t-tubule was determined as described previously (8). In
brief, di-4-AN(F)EPPTEA fluorescence was used to determine the
upstroke of the action potential at the t-tubule. The latency of Ca2
release at each point along the scan line was measured as the time
between the upstroke of the action potential and the time when the
Ca2 signal became 
5 SD above the average prestimulus value.
Latency to time of maximum rate of rise of Ca2 was also determined,
and the SD of latencies for each cell was used as a measure of the
heterogeneity of release. Line scans along the long axis of cells loaded
with fluo-4/AM only were used to monitor spatially averaged whole
cell Ca2 transients. Cells were field stimulated at 0.2 Hz at
1.5 threshold using parallel Pt electrodes.
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Solutions. The standard superfusate for electrophysiology and im-
aging experiments contained (in mmol/l) 133 NaCl, 5 KCl, 1 MgSO4,
1 CaCl2, 1 Na2HPO4, 10 D-glucose and 10 HEPES, pH 7.4 (NaOH).
During electrophysiological recordings, KCl was substituted with
CsCl to inhibit K currents and the pipette solution contained (in
mmol/l) 110 CsCl, 20 tetraethylammonium chloride, 0.5 MgCl2, 5
MgATP, 5 BAPTA, 10 HEPES, and 0.4 GTP-Tris pH 7.2 (CsOH).
H-89 stock solution (10 mmol/l in distilled H2O) was diluted to 20
mol/l in the superfusate for use. Cells were incubated in C3SD
peptide (Pepceuticals Limited, Enderby, Leicestershire, UK, 1 mol/l
in 0.1 mmol/l Ca2) for 1 h at room temperature before use (7, 36).
All experiments were performed at room temperature.
Data presentation. Data are expressed as means SE [of N ani-
mals for in vivo data and of n cells from N animals (n/N) for cellular
measurements]. Data normality was assessed using the Shapiro-Wilk
test, and subsequent testing was performed using a Student’s t-test or
Mann-Whitney test, or one-way ANOVA or Kruskal-Wallis, as ap-
propriate. ICa density-voltage relationship curves were analyzed using
repeated-measures ANOVA with voltage and intervention (i.e. Cav-3
KO) as factors. Single myocyte properties, including those elicited by
a step depolarization to a single voltage, were analyzed with two-way
ANOVA; post hoc tests used Bonferroni correction. The errors in
derived variables (specifically ICa density at the t-tubule membrane)
and the subsequent statistical analysis (unpaired Student’s t-test) were
calculated using propagation of errors from the source measurements.
The limit of statistical confidence was taken as P  0.05.
RESULTS
Cav-3 KO and cardiac function. Western blots of heart
homogenates for Cav-3 (Fig. 1A, left) and the associated
densitometric analysis (Fig. 1A, right) confirmed that Cav-3
KO myocytes did not express detectable levels of Cav-3
protein compared with WT control myocytes.
Echocardiographic assessment of in vivo cardiac function
showed a mild dilated cardiomyopathy, as reported previously
(Fig. 1B) (48). WT and Cav-3 KO mice showed no difference
in heart rate under anesthesia [WT: 436  29 beats/min, N 
6, and Cav-3 KO: 437  19 beats/min, N  7, not significant
(NS)]. Cav-3 KO was associated with a 26% decrease in
fractional shortening (Fig. 1C) and an 18% decrease in ejection
Fig. 1. Caveolin-3 (Cav-3) and in vivo car-
diac function. A: exemplar Western blots of
Cav-3 (18 kDa) and GAPDH (37 kDa) in
homogenates from wild-type (WT) and
Cav-3 knockout (KO) mice (left) and mean
densitometry data for Cav-3 Western blots
(N  5 animals in each group in duplicate;
right). B: exemplar echocardiogram record-
ings from WT (left) and Cav-3 KO (right)
mice. C–F: in vivo measurements of left
ventricular cardiac function by echocardiog-
raphy (WT: N  6 and Cav-3 KO: N  7).
C: fractional shortening (in %). D: ejection
fraction (in %). E: left ventricular internal
diameter at diastole (in mm). F: left ventric-
ular internal diameter at systole (in mm).
*P  0.05; **P  0.01.
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fraction (Fig. 1D), with significant increases in diastolic (Fig.
1E) and systolic (Fig. 1F) left ventricular internal diameters.
Despite the mild impairment of cardiac function, echocardi-
ography showed no significant change in the mass (WT:
156.5  21.0 mg and Cav-3 KO: 160.6  14.4 mg, NS) or
diastolic (WT: 1.1  0.2 mm and Cav-3 KO: 1.0  0.1 mm,
NS) or systolic (WT: 1.6  0.2 mm and Cav-3 KO: 1.5  0.1
mm, NS) posterior wall thickness of the left ventricle. WT
(N  9) and Cav-3 KO (N  8) mice also showed no
significant differences in body weight (WT: 27.1  0.7 g and
Cav-3 KO: 27.8  0.8 g, NS), tibia length (WT: 19.7  0.3
mm and Cav-3 KO: 20.1  0.3 mm, NS), heart weight-to-tibia
length ratio (WT: 10  0.5 mg/mm and Cav-3 KO: 9.4  0.4
mg/mm, NS), or lung weight-to-tibia length ratio (WT:
8.3  0.3 mg/mm and Cav-3 KO: 9  0.7 mg/mm, NS). Thus,
Cav-3 KO was associated with ventricular dilation but not
cardiac hypertrophy or overt failure at 12 wk of age.
Ventricular myocyte morphology. Despite no evidence of
hypertrophy at the organ level, myocytes isolated from Cav-3
KO hearts were increased in width (Fig. 2A) and thus calcu-
lated cell volume (WT: 47.0  2.2 pl, n/N  35/13, and Cav-3
KO: 58.8  3.0 pl, n/N  39/17, P  0.01).
Staining the the surface membrane using di-8-ANEPPS
revealed that t-tubule organization was also altered in Cav-3
Fig. 2. Morphology of isolated myocytes. A:
cell width (top) and length (bottom) mea-
sured from bright-field images of myocytes
from wild-type (WT) and caveolin-3 (Cav-3)
knockout (KO) mice [WT n cells/N hearts
(n/N): 100/4 and Cav-3 KO n/N: 30/4]. B:
confocal images of t-tubules and surface
sarcolemma stained with di-8-ANEPPs from
representative WT (top) and Cav-3 KO (bot-
tom) myocytes. C: t-tubule power (top) and
density (bottom; WT n/N: 20/4 and Cav-3
KO n/N: 20/4). D: t-tubule orientation from
the z-disk plane. E and F: Western blots of
junctophilin-2 (JPH-2; 95 kDa; E) and bridg-
ing integrator-1 (BIN-1; 51 kDa; F) and
GAPDH (37 kDa) (left) with corresponding
mean data (N  5 animals in each group in
duplicate; right). *P  0.05; **P  0.01;
***P  0.001.
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KO myocytes. Figure 2B shows exemplar confocal images of
WT (top) and Cav-3 KO (bottom) myocytes; the latter showed
more prominent gaps in the network and an increase in the
number of axial tubules. Quantification of t-tubule structure
using 2-D fast Fourier transform analysis showed that t-tubule
regularity, assessed as P1/P0 (see METHODS), was decreased in
Cav-3 KO myocytes (Fig. 2C, top). More detailed 3-D analysis
of image stacks revealed that this decrease was due to de-
creased t-tubule density (Fig. 2C, bottom) and changed tubule
orientation (Fig. 2D); there was a 7% reduction in transversely
oriented (0–15°) and an 8% increase in axially oriented (60–
90°) tubules in Cav-3 KO myocytes. However, there was no
significant difference in the number of branch points per length
of tubule (WT: 0.48  0.02 m, n/N  20/4, and Cav-3 KO:
0.45  0.02 m, n/N  20/4, NS).
Since JPH-2 and BIN-1 have been implicated in determining
t-tubule structure and localization of ICa, we investigated
whether Cav-3 KO altered expression of these proteins; how-
ever, JPH-2 and BIN-1 expression levels were not significantly
different between WT and KO cardiac tissue (Fig. 2, E and F).
Thus, Cav-3 KO is associated with cellular hypertrophy and
reduction in t-tubule density as well as changes in tubule
orientation that occurred with no change in JPH-2 or BIN-1
expression.
Distribution of ICa and INCX. Cells from Cav-3 KO mice
showed a 17% increase in cell capacitance (a measure of
membrane area; Fig. 3A), consistent with the 24% increase in
calculated cell volume and 10% decrease of t-tubule density in
these cells.
Figure 3B shows representative records of ICa elicited at 0
mV from intact and DT WT and Cav-3 KO myocytes; Fig. 3C
shows the corresponding mean ICa density-voltage relation-
ships for intact myocytes, demonstrating that Cav-3 KO was
associated with reduced ICa density. This reduction in ICa
density (WT: 	7.53  0.38 pA/pF, n/N  24/7, and Cav-3
KO: 	6.23  0.33 pA/pF, n/N  26/11, at 0 mV, P  0.001;
Fig. 3E) was due to the increase in cell capacitance because
absolute ICa magnitudes were not significantly different in the
two cell types (WT: 	1,299  70 pA, n/N  24/7, and KO:
	1,397  81 pA, n/N  26/11, at 0 mV, NS; Fig. 3F).
To examine the possible redistribution of ICa between sur-
face and t-tubule membranes, some cells were detubulated
before measurement of ICa. DT had no significant effect on
calculated cell volume but decreased cell capacitance in both
WT and Cav-3 KO mice (Fig. 3A), consistent with loss of
t-tubules, as previously described (5, 6, 32). Capacitance was
not significantly different in DT WT and Cav-3 KO myocytes,
suggesting that the increased capacitance observed in intact
Fig. 3. Membrane capacitance and Ca2 cur-
rent (ICa). A: cell capacitance (in pF) of
intact and detubulated (DT) myocytes used
for electrophysiology from wild-type (WT)
mice [intact n cells/N hearts (n/N): 35/13 and
DT n/N  38/13] and caveolin-3 (Cav-3)
knockout (KO) mice (intact n/N: 39/17 and
DT n/N: 43/14). B: exemplar records of ICa
recorded at 0 mV from intact and DT WT
and Cav-3 KO myocytes. C and D: mean ICa
density-voltage relations from intact (C; WT
n/N 24/7 and Cav-3 KO n/N 26/11) and
DT (D; WT n/N  28/9 and Cav-3 KO
n/N 31/9) WT and Cav-3 KO myocytes. E
and F: mean ICa density (E) and absolute ICa
(F) at 0 mV in intact and DT (“surface”)
cells and calculated at the t-tubule mem-
brane (“t-tubule”) for WT (open columns)
and Cav-3 KO (solid columns) myocytes.
*P  0.05; **P  0.01; ***P  0.001.
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Cav-3 KO myocytes was predominantly due to an increase in
t-tubule area.
DT significantly decreased ICa density in WT and Cav-3 KO
myocytes to a level that was not significantly different in the
two cell types (Fig. 3D), showing that ICa density at the surface
membrane was not significantly different in Cav-3 KO and WT
myocytes (Fig. 3E). However, absolute ICa was significantly
higher in Cav-3 KO than WT myocytes (DT WT: 	465  25
pA, n/N  28/9, and DT Cav-3 KO: 	572  33 pA, n/N 
31/9, at 0 mV, P  0.05; Fig. 3F), so that despite a small (NS)
increase in capacitance, ICa density was slightly (NS) higher at
the surface of Cav-3 KO myocytes (Fig. 3, D and E). These
data suggest that the significant decrease in ICa density ob-
served in intact Cav-3 KO myocytes is due to a selective
decrease in t-tubular ICa density. This was confirmed by cal-
culation of t-tubular ICa density from these data, as previously
described (8), which showed an ~51% decrease in t-tubular ICa
density in Cav-3 KO compared with WT myocytes (Fig. 3E)
with no change in absolute t-tubular ICa (Fig. 3F). Thus, the
decrease of ICa density observed in Cav-3 KO ventricular
myocytes is due to a decrease in t-tubular ICa density as the
result of an increase in t-tubule area.
The scaffolding domain of Cav-3 has been suggested to bind
directly to many signaling proteins, including adenylyl cyclase,
thereby inhibiting their activity (19, 22, 46). To investigate
whether loss of such inhibition might mask an underlying
decrease in ICa in KO myocytes, we investigated the effect of
C3SD peptide, which mimics the Cav-3 scaffolding domain, on
ICa in Cav-3 KO myocytes. However, C3SD had no effect on
ICa density (Cav-3 KO:	7.59  0.48, pA/pF, n/N 28/4, and
Cav-3 KO plus C3SD: 	7.96  0.52 pA/pF, n/N  28/4, at 0
mV, NS), although previous work has shown that tonic Cav-
3-dependent stimulation of ICa is inhibited by C3SD in WT
myocytes (11, 33). The lack of effect of C3SD on ICa in KO
myocytes suggests that such stimulation is absent in these cells
and thus other factors might be involved in maintaining abso-
lute ICa in KO myocytes.
We therefore investigated whether LTCC expression was
increased in KO myocytes, which could help maintain ICa.
Figure 4A shows example Western blots for the LTCC 1c-
subunit and mean data, which show that LTCC expression was
unchanged in Cav-3 KO hearts compared with WT control
hearts.
We also investigated whether ICa was maintained in KO
myocytes as a result of increased PKA-dependent stimulation,
since Cav-3 has been implicated in localizing and regulating
constitutive PKA activity (41). Figure 4 shows the effect of the
PKA inhibitor H-89 on mean ICa density-voltage relationships
recorded from intact (Fig. 4B) and DT (Fig. 4C) myocytes from
WT and Cav-3 KO mice. H-89 caused similar decreases in ICa
density in intact (WT: 70% and Cav-3 KO: 77%, NS) and DT
(WT: 70% and Cav-3 KO: 79%, NS) myocytes, so that ICa
Fig. 4. Ca2 current (ICa) in the presence of
H-89. A: Western blots of the L-type Ca2
channel (LTCC; 160 kDa) and GAPDH (37
kDa; left) and mean densitometry data (N 
5 animals in each group in duplicate; right).
B and C: ICa density-voltage relations re-
corded in the presence of H-89 from intact
[B; wild type (WT) n cells/N hearts (n/N):
16/9 and caveolin-3 (Cav-3) knockout (KO)
n/N: 8/5] and detubulated (DT; C; WT n/N:
14/7 and Cav-3 KO n/N: 11/3) WT and
Cav-3 KO myocytes. D and E: mean ICa
density (D) and absolute ICa (E) at 0 mV in
the presence of H-89 in intact and DT (“sur-
face”) cells and calculated at the t-tubule
membrane (“t-tubule”) for WT (open col-
umns) and Cav-3 KO (solid columns) myo-
cytes. *P  0.05; **P  0.01; ***P 
0.001.
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distribution was qualitatively similar in the absence and pres-
ence of H-89 in the two cells types (compare Figs. 3E and 4D).
In the presence of H-89, absolute ICa was not significantly
different in intact myocytes (WT: 	471  66 pA, n/N  16/9,
and Cav-3 KO: 	321  24 pA, n/N  8/5, at 0 mV, NS);
however, in contrast to the data obtained in the absence of
H-89, and as shown in Fig. 4E, absolute ICa at the surface
membrane was no longer significantly larger (WT: 	127  25
pA, n/N  14/7, and Cav-3 KO: 	140  17 pA, n/N  11/3,
at 0 mV, NS) and absolute t-tubular ICa was now significantly
smaller in KO myocytes (WT: 	382  74 pA, n/N  54/16,
and Cav-3 KO: 	207  29 pA, n/N  32/8, at 0 mV, P 
0.05). These data suggest significant tonic stimulation of ICa by
PKA at both the surface and t-tubule membranes in WT and
KO myocytes, which is slightly greater in KO myocytes,
helping to maintain absolute ICa.
Since Cav-3 KO decreased t-tubular ICa density, we also
investigated the effect of Cav-3 KO on the main Ca2 efflux
pathway, INCX. Figure 5A shows exemplar records of the rise
of intracellular Ca2 caused by application of 10 mM caffeine
to intact WT and KO myocytes (top) and the accompanying
inward currents (INCX; bottom), showing no difference between
the two cell types. Figure 5B shows corresponding traces
obtained from DT WT and Cav-3 KO myocytes. Mean data
showed that there was no difference in the amplitude of the
caffeine-induced rise of intracellular Ca2 in intact and DT
WT and Cav-3 KO myocytes (Fig. 5C), suggesting no differ-
ence in SR Ca2 content, and that INCX density, calculated as
previously described (26), is similar at the surface and t-tubule
membranes of WT myocytes, as previously described (26), and
was not significantly different in WT and KO myocytes (Fig.
5D). However, the ratio of INCX at the cell surface to INCX at
the t-tubules decreased from 1.59  0.28 in WT myocytes to
0.70  0.10 in KO myocytes (P  0.01), suggesting a redis-
tribution of INCX from the cell surface to the t-tubules after
Cav-3 KO.
Intracellular Ca2 handling. Since t-tubular ICa and SR
Ca2 content are key determinants of SR Ca2 release, we
investigated the effect of Cav-3 KO on Ca2 release. Figure
6A shows representative systolic Ca2 transients recorded
from WT and Cav-3 KO myocytes, showing that Cav-3 KO
had little effect on Ca2 transient amplitude or time course.
Mean data show that Cav-3 KO did not significantly change
Ca2 transient amplitude, time to peak, or time to half decay
(Fig. 6B).
Closer examination also revealed little difference in local
t-tubular CICR. Figure 6C shows representative line-scan im-
ages of fluo-4 fluorescence along a t-tubule with spatially
averaged di-4-AN(F)EPPTEA fluorescence recorded from the
t-tubule membrane in WT (top) and Cav-3 KO (bottom) myo-
cytes. Measurement of the latency from the start of the action
potential upstroke (yellow lines) to the initial Ca release along
the t-tubule (red lines) revealed that Cav-3 KO had almost no
effect (Fig. 6D). Similarly, neither the delay to the maximum
rate of rise of Ca2 (blue lines; mean data not shown) nor the
variability in latency along the t-tubule (“heterogeneity”; Fig.
6D) were different in WT and Cav-3 KO myocytes.
DISCUSSION
Previous work has shown that transverse aortic constriction
(TAC)-induced hypertrophy and HF are associated with de-
creased cardiac Cav-3 expression (11). Although it has been
suggested that Cav-3 inhibits hypertrophic signaling pathways
(28, 48), the extent to which decreased expression underlies the
cellular features of HF was unclear. The present study shows
that Cav-3 KO causes mild dilated cardiomyopathy and cellu-
lar hypertrophy without overt HF. Cav-3 KO myocytes showed
morphological and functional similarities to those from TAC-
induced hypertrophic hearts (11), including cellular hypertro-
phy, disrupted t-tubule structure, and reduced t-tubular ICa. Our
data suggest that cellular hypertrophy underlies the accompa-
nying decrease in density of t-tubules and t-tubular ICa. Thus,
decreased Cav-3 expression may underlie these changes in
pathological conditions.
In vivo and structural changes after Cav-3 KO. The left
ventricular dilatation and reduced fractional shortening and
ejection fraction observed in vivo in Cav-3 KO mice confirm
previous work using a different Cav-3 KO mouse line (48).
These changes are unlikely to be due to changes in cardiac
Fig. 5. Intracellular Ca2 and Na/Ca2
exchanger current (INCX) during application
of caffeine. A and B: exemplar records of the
rise of intracellular Ca2 (top) caused by
application of 10 mM caffeine to intact (A)
and detubulated (DT; B) wild-type (WT) and
knockout (KO) myocytes and the accompa-
nying inward currents (INCX; bottom). C:
mean amplitude of the caffeine-induced rise
of intracellular Ca2 [intact: WT n cells/N
hearts (n/N): 11/6 and Cav-3 KO n/N 
13/6; DT: WT n/N 10/4, Cav-3 KO n/N
12/3]. D: distribution of INCX density, calcu-
lated as previously described (26).
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load, since blood pressure is unaltered after Cav-3 KO (48).
They also occurred with no change in left ventricular mass,
wall thickness, heart weight-to-tibia length ratio, or lung
weight-to-tibia length ratio, and thus there is little evidence of
cardiac hypertrophy or overt HF. Thus, since cellular hyper-
trophy was observed in isolated Cav-3 KO myocytes, loss of
cell number must have occurred to maintain heart weight,
consistent with the signs of cell death reported by Woodman et
al. (48).
Cellular hypertrophy in Cav-3 KO myocytes was accompa-
nied by an increase in cell capacitance, a decrease in t-tubule
density, fewer transverse and more longitudinal tubules, and
reduced t-tubule regularity. However, after DT, membrane
capacitance was similar in WT and KO myocytes; this suggests
that the increased capacitance in intact KO cells was due
predominantly to increased t-tubule membrane area. The in-
crease in capacitance is unlikely to be due to the inhibitory
effect of Cav-3 KO on caveolae formation or cholesterol
trafficking because 1) it occurred predominantly at the t-tu-
bules, 2) loss of caveolae would decrease capacitance, and 3)
cholesterol depletion appears to have no effect on either t-tu-
bule or surface membrane capacitance (25). We therefore used
a previously published geometric model of ventricular cell
morphology (33) to investigate the relationship between the
observed changes in cell size and membrane areas. We incor-
porated the t-tubule membrane fraction determined from ca-
pacitance measurements in WT cells (31.2%) into the model
and then simulated the increase in cell size and decrease in
t-tubule density (11.3%) observed experimentally in KO myo-
cytes. This resulted in a 12.2% increase in whole cell capaci-
tance, consistent with that observed experimentally (17  7%),
and a t-tubular membrane fraction of 39.6%, which is very
similar to that observed experimentally (37.6  2.3%). This is
the result of an increase in t-tubule area and fraction, predom-
inantly caused by the increase in cell width (see Supplemental
Figure S1 in Ref. 33), offset by the decrease in t-tubule density
observed in KO myocytes. Thus, the changes observed in
whole cell, surface membrane, and t-tubule capacitance, and
Fig. 6. Systolic Ca2 transients and local Ca2 release. A:
representative Ca2 transients recorded from wild-type
(WT) and caveolin-3 (Cav-3) knockout (KO) myocytes. B:
Ca2 transient amplitude, time to peak, and time to half
decay (T50) measured from Ca2 transients of WT [n
cells/N hearts (n/N): 12/3] and Cav-3 KO (n/N  14/3)
cells. C: representative optical measurements of the rising
phase of the Ca2 transient and associated average t-tubular
di-4-AN(F)EPPTEA signal. AP, action potential. D: mean
latency and heterogeneity of sarcoplasmic reticulum Ca2
release in WT (n/N  10/3) and Cav-3 KO (n/N  26/5)
myocytes.
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thus fractional area, are consistent with, and can be explained
by, the changes in cell geometry (cell size and t-tubule density)
observed after Cav-3 KO.
The mechanism by which Cav-3 regulates cell and t-tubule
growth is not clear. However, the present data showing that
Cav-3 KO leads to cellular hypertrophy is consistent with the
idea that Cav-3 inhibits the hypertrophic p42/44 MAPK path-
way in the heart (48). The changes in the present study
occurred with no change in JPH-2 or BIN-1 expression, sug-
gesting 1) that the decreased expression of these proteins
observed in HF (e.g., Refs. 11 and 13) is not secondary to the
associated decrease in Cav-3 expression and 2) that the effects
of Cav-3 KO cannot be ascribed to changes of JPH-2 and
BIN-1 expression and thus that Cav-3 KO itself is responsible
for the changes in t-tubule morphology. This may be the result
of cellular hypertrophy without a commensurate increase in
t-tubular growth or secondary to other changes, for example,
mechanical changes (30) or changes in JPH-2 or BIN-1 distri-
bution and/or function occurring as a result of Cav-3 KO.
These data suggest, therefore, that decreased Cav-3 expres-
sion contributes to the changes in t-tubule morphology ob-
served in hypertrophy and HF. However, previous work from
several laboratories has also implicated decreased expression
of JPH-2 and BIN-1 in the altered t-tubule structure observed
in HF (13, 24, 42, 43), and it is notable that the changes
observed in the present study were smaller than those typically
observed in HF, despite complete ablation of Cav-3 compared
with the ~40% decrease reported in HF (11). Thus, other
mechanisms, such as decreased JPH-2 and BIN-1 expression,
must occur in parallel with the decrease in Cav-3 expression to
account for the changes in t-tubule structure and ECC observed
in HF.
In summary, Cav-3 KO causes cardiac dilatation, cellular
hypertrophy, and changes in t-tubule organization; these cel-
lular changes are similar to those observed in hypertrophic
hearts but less marked than those in overt failure (11).
ICa and INCX in KO myocytes. The present study shows that
Cav-3 KO decreases t-tubular ICa density by increasing mem-
brane area with no significant change in absolute ICa, which is
maintained, in part, by slightly greater PKA-dependent stimu-
lation in Cav-3 KO myocytes. The decrease in density results
in more uniform distribution of ICa between the t-tubule and
surface membranes and was sufficient to cause a decrease in
whole cell ICa density.
C3SD inhibits ICa in WT myocytes (11, 33) but had no effect
on ICa in Cav-3 KO myocytes, which suggests, first, that the
inhibitory effect of C3SD is mediated via interaction with
Cav-3 rather than by a direct effect on the LTCC or its
regulatory proteins. Recent studies have questioned the role of
the Cav-3 scaffolding domain in binding to its protein partners
(12, 18, 38); the observation that a peptide mimicking the
scaffolding domain only inhibits ICa in the presence of Cav-3
suggests that the effect of Cav-3 on ICa is not due to the scaffold-
ing domain binding alone but supports a role for the scaffolding
domain in the physiological function of Cav-3. Second, it suggests
that Cav-3-dependent stimulation of ICa is lost in Cav-3 KO
myocytes and thus, third, that another, Cav-3-independent,
mechanism contributes to the maintenance of ICa in Cav-3 KO
myocytes. This Cav-3-independent mechanism is likely to
involve PKA, because the inhibitory effect of H-89 on ICa
appeared greater in KO than WT myocytes: the larger absolute
ICa at the cell surface in Cav-3 KO myocytes in the absence of
H-89 was no longer significant in the presence of H-89 and the
similar absolute ICa at the t-tubules became significantly
smaller in KO myocytes in the presence of H-89. Thus,
although the distribution of ICa density was qualitatively sim-
ilar in WT and Cav-3 KO myocytes in the absence and
presence of H-89, it appeared to have a greater inhibitory effect
on ICa in Cav-3 KO myocytes, consistent with increased
stimulation of ICa by PKA in these cells (1). Interestingly,
TAC-induced hypertrophy and HF are also associated with
decreased t-tubular ICa density because of increased t-tubule
surface area with no significant change in absolute ICa and with
loss of response of ICa to C3SD (11). This suggests that
Cav-3-dependent stimulation of ICa is absent and thus absolute
ICa is maintained in both Cav-3 KO and after TAC by other
factor(s), which appear to include increased PKA activity (the
present study and Refs. 31 and 44). This also suggests that
decreased Cav-3 expression may, in part, underlie these
changes in hypertrophy and failure; although it remains possi-
ble that the changes observed after Cav-3 KO are secondary to
remodeling, such changes would also, presumably, occur be-
cause of decreased Cav-3 expression under pathological con-
ditions.
Although the present data are consistent with previous work
showing PKA-dependent stimulation of ICa at the t-tubule and
surface membranes of mouse myocytes (33), it is unclear why
Cav-3 KO increases PKA-dependent stimulation of ICa at the
t-tubular and surface membranes, since Cav-3 colocalizes with
LTCCs and components of the PKA cascade in a signaling
domain at t-tubules (2). Furthermore, previous work has shown
that acute treatment of cells with C3SD peptide inhibits local
Cav-3-dependent stimulation of a subset of LTCCs by PKA,
probably by disrupting the signaling domain (2, 7, 9). Presum-
ably, chronic ablation of Cav-3 disrupts the localization of
PKA activity to signaling domains, resulting in the stimulation
of more LTCCs.
The reason for the smaller absolute t-tubular ICa in KO
myocytes in the presence of H-89 is also unclear since expres-
sion of LTCCs and BIN-1 (which has been implicated in
trafficking LTCCs to the t-tubules) was unchanged. It could be
due to loss of Cav-3-dependent stimulation of ICa (above)
without the compensatory increase in stimulation by PKA but
may reflect relocation of LTCCs. Together, however, the data
show that the decrease in t-tubule, and thus whole cell, ICa
density in Cav-3 KO myocytes is due to the increase in t-tubule
area, partly offset by increased stimulation by PKA.
In contrast to ICa, Cav-3 KO did not alter INCX density in the
intact cell, nor did it significantly alter INCX at surface and
t-tubule membranes. However, Cav-3 KO significantly de-
creased the ratio of INCX at the cell surface to INCX at the
t-tubules, suggesting redistribution of INCX from the cell sur-
face to the t-tubular membrane. This redistribution is the
reverse of that observed for ICa, so that Cav-3 appears to have
reciprocal effects on the distributions of ICa and INCX, although
the mechanism of regulation of INCX distribution is unknown.
However, the lack of effect of Cav-3 KO on INCX density in the
intact cell implies some upregulation of INCX so that its density
remains unchanged despite the cellular hypertrophy induced by
Cav-3 KO.
SR Ca2 release. Although ICa density was reduced in Cav-3
KO myocytes, particularly at the t-tubules, neither the ampli-
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tude nor time course of the whole cell Ca2 transient amplitude
was altered. More detailed examination of CICR by measuring
the latency and heterogeneity of local Ca2 release along a
t-tubule also revealed no effect of Cav-3 KO.
Ca2 release was maintained with no significant change in
SR Ca2 content and may be explained by redundancy in
t-tubular ICa in ventricular myocytes (14). However, it is also
possible that 1) dyadic ICa was maintained, since absolute ICa
was unchanged in KO myocytes; 2) a larger population of
LTCCs is stimulated by PKA in KO myocytes (above), helping
to maintain CICR; 3) Ca2/calmodulin-dependent protein ki-
nase, which was inhibited by BAPTA for the measurement of
ICa, helps maintain ICa in intact myocytes; and 4) RyR sensi-
tivity increased because of increased PKA-dependent phos-
phorylation.
However, the lack of effect of Cav-3 KO on local Ca2
release compared with the increased latency and heterogeneity
of Ca2 release at the t-tubule observed in HF suggests that
other factors may be affecting Ca2 release in HF. One
possibility is dyadic disruption in HF as a result of decreased
expression of JPH-2 and BIN-1, which have been implicated in
dyad formation (13, 24, 42, 43), whereas expression of these
proteins was unchanged in KO myocytes. Similarly, the rela-
tively small disruption of t-tubule structure compared with HF
might explain why there was relatively little effect on the
systolic Ca2 transient. Thus, the reduction in ICa density and
disruption of t-tubule organization associated with Cav-3 KO
were insufficient to cause significant changes of Ca2 release,
in contrast to those observed in HF.
These data also suggest that the decrease in ejection fraction
observed in Cav-3 KO mice in vivo is not due to altered Ca2
release, although it remains possible that Ca2 transient am-
plitude may be altered by Cav-3 KO at higher (physiological)
frequencies. However, the decrease occurred in the presence of
increased heart size; since wall tension will increase with
dilation, the law of Laplace shows that a reduced ejection
fraction does not necessarily imply reduced contractility. Im-
paired cardiac function in KO mice is also associated with an
increase in extracellular matrix and fibrosis (48), which, with
possible changes in neurohumoral influences in vivo, may
contribute to the decrease in ejection fraction.
Conclusions. These data show that decreased Cav-3 ex-
pression is likely to contribute to the cellular hypertrophy,
disrupted t-tubule structure, and decreased ICa density ob-
served in hypertrophy but not with the more marked changes
observed in HF.
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